| 1. | EXECUTIVE SUMMARY |
| 1.1. | What is industrial biomanufacturing? |
| 1.2. | Biomanufacturing Specialty Chemicals 2027-2037: Scope |
| 1.3. | Market trends and drivers in industrial biomanufacturing (1) |
| 1.4. | Market trends and drivers in industrial biomanufacturing (2) |
| 1.5. | Synthetic biology as applied to industrial biomanufacturing |
| 1.6. | Technology trends in industrial biomanufacturing |
| 1.7. | Overview of alternative feedstocks for industrial biomanufacturing |
| 1.8. | Major market challenges for industrial biomanufacturing |
| 1.9. | Technical challenges for industrial biomanufacturing |
| 1.10. | Products derived from industrial biomanufacturing: Overview |
| 1.11. | Specialty chemicals that can be produced by industrial biomanufacturing |
| 1.12. | Company landscape in biomanufacturing specialty chemicals |
| 1.13. | Biomanufactured fragrances and aromatics: Emerging company landscape |
| 1.14. | Other emerging biomanufactured beauty products and status |
| 1.15. | Technology Readiness Level (TRL): Cosmetics & personal care |
| 1.16. | Biosurfactants: Company landscape |
| 1.17. | Technology challenges and opportunities for bioenergy enzymes |
| 1.18. | Technology Readiness Level (TRL): Enzymes for bioenergy applications |
| 1.19. | Cost-performance metrics for thermostable enzymes |
| 1.20. | Technology readiness levels of enzyme applications in bioenergy |
| 1.21. | Selected enzymatic approaches to CO2 capture and conversion |
| 1.22. | Technology Readiness Level (TRL): Sweeteners |
| 1.23. | Technology Readiness Level (TRL): Biomanufactured pigments |
| 1.24. | Biomanufactured specialty chemicals overall market forecast 2027-2037 |
| 1.25. | Biomanufactured specialty chemicals overall market forecast 2027-2037: Market share |
| 1.26. | Industrial biomanufacturing for commodity chemicals 2027-2037 |
| 1.27. | Access More With an IDTechEx Subscription |
| 2. | INTRODUCTION |
| 2.1. | Introduction to specialty chemicals |
| 2.2. | Biotechnology application |
| 2.3. | What is industrial biomanufacturing? |
| 2.4. | The bioeconomy and industrial biomanufacturing |
| 2.5. | Precision fermentation: Definition and scope |
| 2.6. | Biomanufacturing Specialty Chemicals 2027-2037: Scope |
| 2.7. | Products derived from industrial biomanufacturing: Overview |
| 2.8. | Molecules that can be produced through biomanufacturing: Cosmetics |
| 2.9. | Molecules that can be produced through biomanufacturing: Food additives |
| 2.10. | Molecules that can be produced through biomanufacturing: Enzymes (1) |
| 2.11. | Molecules that can be produced through biomanufacturing: Enzymes (2) |
| 2.12. | Molecules that can be produced through biomanufacturing: Pigments |
| 2.13. | Company landscape in biomanufacturing specialty chemicals (1) |
| 2.14. | Company landscape in biomanufacturing specialty chemicals (2) |
| 2.15. | Market trends and drivers in industrial biomanufacturing (1) |
| 2.16. | Market trends and drivers in industrial biomanufacturing (2) |
| 3. | MARKET ANALYSIS |
| 3.1. | Market Drivers for Industrial Biomanufacturing |
| 3.2. | Market drivers: Demand for biobased products |
| 3.3. | Market drivers: Government support of biomanufacturing |
| 3.4. | Market drivers: Carbon taxes |
| 3.5. | Economic Viability of Industrial Biomanufacturing |
| 3.6. | Factors affecting the economic viability of industrial biomanufacturing projects |
| 3.7. | Effect of the price of Brent crude on biobased products |
| 3.8. | The Green Premium |
| 3.9. | The effect of biomass feedstock prices on the bioplastics market |
| 3.10. | Effect of cell factory on cost |
| 3.11. | How scale-up affects cost |
| 3.12. | Zymergen: Case study on economics of synthetic biology |
| 3.13. | Case study: LanzaTech |
| 3.14. | Case study: Solazyme |
| 3.15. | Synthetic biology: Shift from commodity products to lower volume, high value markets |
| 3.16. | Major market challenges for industrial biomanufacturing |
| 4. | CELL FACTORIES FOR INDUSTRIAL BIOMANUFACTURING |
| 4.1. | Cell factories for biomanufacturing: Factors to consider |
| 4.2. | Cell factories for biomanufacturing: A range of organisms (1) |
| 4.3. | Cell factories for biomanufacturing: A range of organisms (2) |
| 4.4. | Escherichia coli (E.coli) |
| 4.5. | Corynebacterium glutamicum (C. glutamicum) |
| 4.6. | Bacillus subtilis (B. subtilis) |
| 4.7. | Saccharomyces cerevisiae (S. cerevisiae) |
| 4.8. | Yarrowia lipolytica (Y. lipolytica) |
| 4.9. | Purple bacteria: Introduction |
| 4.10. | Purple bacteria: Applications and outlook |
| 4.11. | Purple bacteria: SWOT analysis |
| 4.12. | Purple bacteria case study: Symbiobe |
| 4.13. | Non-model organisms for industrial biomanufacturing |
| 5. | TECHNOLOGY DEVELOPMENTS |
| 5.1. | Synthetic biology |
| 5.1.1. | Synthetic biology: The design and engineering of biological systems |
| 5.1.2. | Synthetic biology: Manipulating the central dogma |
| 5.1.3. | The vast scope of synthetic biology |
| 5.1.4. | The process of synthetic biology: Design, build and test |
| 5.1.5. | Synthetic biology: Why now? |
| 5.1.6. | Synthetic biology: From pharmaceuticals to consumer products |
| 5.1.7. | Synthetic biology: Disrupting existing supply chains |
| 5.1.8. | Synthetic biology: Drivers and barriers for adoption |
| 5.1.9. | Synthetic biology as applied to industrial biomanufacturing |
| 5.1.10. | Tools and Techniques of Synthetic Biology |
| 5.1.11. | Tools and techniques of synthetic biology: Overview |
| 5.1.12. | DNA synthesis |
| 5.1.13. | Introduction to CRISPR-Cas9 |
| 5.1.14. | CRISPR-Cas9: A bacterial immune system |
| 5.1.15. | CRISPR-Cas9's importance to synthetic biology |
| 5.1.16. | Protein/enzyme engineering |
| 5.1.17. | Computer-aided design |
| 5.1.18. | Commercial examples of engineered proteins in industrial applications |
| 5.1.19. | Strain construction and optimization |
| 5.1.20. | Synergy between synthetic biology and metabolic engineering |
| 5.1.21. | Framework for developing industrial microbial strains |
| 5.1.22. | The problem with scale |
| 5.2. | Cell-free biomanufacturing |
| 5.2.1. | Introduction to cell-free systems |
| 5.2.2. | Cell-free versus cell-based systems |
| 5.2.3. | Cell-free systems in the context of industrial biomanufacturing |
| 5.2.4. | Cell-free systems for industrial biomanufacturing |
| 5.2.5. | Commercial implementation of cell-free systems: Solugen |
| 5.2.6. | Startups pursuing cell-free systems for industrial biomanufacturing (1) |
| 5.2.7. | Startups pursuing cell-free systems for industrial biomanufacturing (2) |
| 5.2.8. | Immobilized enzymes in industrial biomanufacturing (1) |
| 5.2.9. | Immobilized catalysts in industrial biomanufacturing (2) |
| 5.3. | Improvement of biomanufacturing processes |
| 5.3.1. | Continuous vs batch biomanufacturing |
| 5.3.2. | Continuous perfusion bioreactors |
| 5.3.3. | Benefits and challenges of continuous biomanufacturing |
| 5.3.4. | Continuous vs batch biomanufacturing: Key fermentation parameter comparison |
| 5.3.5. | Continuous fermentation: DAB.bio |
| 5.3.6. | Simultaneous saccharification and fermentation (SSF) |
| 5.3.7. | Sterility-free fermentation |
| 5.3.8. | Hybrid biotechnological-chemical approaches |
| 5.3.9. | Process intensification and high-cell-density fermentation |
| 5.3.10. | Submerged liquid fermentation bioreactors (1) |
| 5.3.11. | Submerged liquid fermentation bioreactors (2) |
| 5.3.12. | Solid state fermentation |
| 5.3.13. | Solid state fermentation bioreactors |
| 5.3.14. | Downstream processing (DSP) improvements (1) |
| 5.3.15. | Downstream processing (DSP) improvements (2) |
| 5.3.16. | Tangential flow filtration (TFF) in downstream bioprocessing |
| 5.4. | Automation and AI for biomanufacturing |
| 5.4.1. | Robotics: Enabling hands-free and high throughput science |
| 5.4.2. | Robotic cloud laboratories |
| 5.4.3. | Automating organism design and closing the loop |
| 5.4.4. | Machine learning de novo protein prediction |
| 5.4.5. | AI-driven protein/enzyme design companies |
| 5.4.6. | Machine learning to improve biomanufacturing processes |
| 5.4.7. | AI-driven fermentation platform companies |
| 5.4.8. | Overview of machine learning based improvements for biomanufacturing |
| 5.5. | Industrial biomanufacturing for sustainability |
| 5.5.1. | Industrial biomanufacturing as a sustainable technology |
| 5.5.2. | Routes for carbon capture in industrial biomanufacturing |
| 5.5.3. | Autotrophic bacteria for carbon capture through biomanufacturing |
| 5.6. | Alternative feedstocks for biomanufacturing |
| 5.6.1. | Why use alternative feedstocks for industrial biomanufacturing? |
| 5.6.2. | Food, land, and water competition |
| 5.6.3. | C1 feedstocks: Metabolic pathways |
| 5.6.4. | C1 feedstocks: Economic benefits |
| 5.6.5. | C1 feedstocks: Challenges |
| 5.6.6. | Non-methane C1 feedstocks |
| 5.6.7. | C1 feedstocks: Products |
| 5.6.8. | C1 feedstocks: Gas fermentation |
| 5.6.9. | C2 feedstocks |
| 5.6.10. | C2 feedstocks: Products segmented by feedstock |
| 5.6.11. | C1 and C2 feedstocks: Commercial activity (1) |
| 5.6.12. | C1 and C2 feedstocks: Commercial activity (2) |
| 5.6.13. | Lignocellulosic biomass feedstocks |
| 5.6.14. | Lignocellulosic biomass feedstocks: Challenges |
| 5.6.15. | Lignocellulosic biomass feedstocks: Challenges |
| 5.6.16. | Lignocellulosic biomass feedstocks: Products |
| 5.6.17. | Lignocellulosic feedstocks: Commercial activity |
| 6. | BLUE BIOTECHNOLOGY |
| 6.1. | What is blue biotechnology? |
| 6.2. | Main biocatalysts of blue biotechnology: Cyanobacteria and algae |
| 6.3. | Cyanobacteria |
| 6.4. | Algae |
| 6.5. | Key drivers and challenges for blue biotechnology |
| 6.6. | Selected startups in blue biotechnology |
| 7. | PRODUCTS DERIVED FROM INDUSTRIAL BIOMANUFACTURING |
| 7.1.1. | Products derived from industrial biomanufacturing: Overview |
| 7.2. | Cosmetics and personal care |
| 7.2.1. | Introduction |
| 7.2.2. | Biomanufacturing in the beauty sector |
| 7.2.3. | Incumbent beauty ingredient supply chain (1) |
| 7.2.4. | Incumbent beauty ingredient supply chain (2) |
| 7.2.5. | Incumbent beauty ingredient supply chain company landscape (1) |
| 7.2.6. | Incumbent beauty ingredient supply chain company landscape (2) |
| 7.2.7. | Biomanufactured beauty ingredient supply chain and processing |
| 7.2.8. | Established biotech-derived beauty ingredients |
| 7.2.9. | Emerging biotech-derived beauty ingredients |
| 7.2.10. | Challenges in the biomanufactured beauty ingredients sector |
| 7.2.11. | Fragrances and Aromatic Compounds |
| 7.2.12. | Biotech-derived fragrance precursors |
| 7.2.13. | Fragrances and aromatic compounds overview |
| 7.2.14. | Fragrances and aromatic compounds |
| 7.2.15. | Biomanufactured fragrances and aromatics: Emerging company landscape |
| 7.2.16. | Biomanufactured fragrances and aromatics: Emerging company landscape |
| 7.2.17. | Fragrances and aromatic compounds: Company landscape (1) |
| 7.2.18. | Fragrances and aromatic compounds: Company landscape (2) |
| 7.2.19. | Ambroxan |
| 7.2.20. | Biosurfactants |
| 7.2.21. | Biosurfactants: Introduction |
| 7.2.22. | Biosurfactants: Trends |
| 7.2.23. | Biosurfactants: Company landscape (1) |
| 7.2.24. | Biosurfactants: Company landscape (2) |
| 7.2.25. | Biomanufactured surfactants: Company landscape |
| 7.2.26. | Surfactants: Functional roles and market importance in industrial biomanufacturing |
| 7.2.27. | Rhamnolipids |
| 7.2.28. | Sophorolipids |
| 7.2.29. | Mannosylerythritol lipids (MELs) |
| 7.2.30. | Cellobiose lipids |
| 7.2.31. | Designer glycolipids and lipopeptides via synthetic biology |
| 7.2.32. | Polysaccharide-based amphiphiles |
| 7.2.33. | Industrial biomanufacturing surfactants commercial landscape |
| 7.2.34. | Hyaluronic Acid |
| 7.2.35. | Hyaluronic acid: Fermentation-based production for moisturizing |
| 7.2.36. | Hyaluronic acid: Fermentation-based production for moisturizing (2) |
| 7.2.37. | Function-driven customization of biotech-derived hyaluronic acid formulations |
| 7.2.38. | Function-driven customization of biotech-derived hyaluronic acid formulations |
| 7.2.39. | Hyaluronic acid technologies: Functions and key players |
| 7.2.40. | Hyaluronic acid: Company landscape (1) |
| 7.2.41. | Hyaluronic acid: Company landscape (2) |
| 7.2.42. | Hyaluronic Acid |
| 7.2.43. | Emollients |
| 7.2.44. | Squalene and Squalane: Industrial biomanufacturing alternatives to shark liver oil (1) |
| 7.2.45. | Squalene and Squalane: Industrial biomanufacturing alternatives to shark liver oil (2) |
| 7.2.46. | Squalene |
| 7.2.47. | Squalene and Squalane: Company landscape |
| 7.2.48. | Squalene and Squalane: Company landscape |
| 7.2.49. | Collagen |
| 7.2.50. | Collagen in skin and personal care products |
| 7.2.51. | Collagen in skin and personal care products |
| 7.2.52. | Collagen: Company landscape |
| 7.2.53. | Collagen: Company landscape (2) |
| 7.2.54. | Collagen: Company landscape |
| 7.2.55. | Comparison of native, hydrolyzed, and recombinant collagen structures |
| 7.2.56. | Comparison of native, hydrolyzed, and recombinant collagen structures |
| 7.2.57. | Engineered collagen derivatives with enhanced bioactivity |
| 7.2.58. | Collagen (e.g. Geltor) |
| 7.2.59. | Other products for cosmetics |
| 7.2.60. | Bio-based UV filters and photoprotective compounds |
| 7.2.61. | Case study: OneSkin - OS 01 Senotherapeutic Peptide |
| 7.2.62. | Market Analysis and Benchmarking |
| 7.2.63. | Biomanufactured beauty ingredient production capacities |
| 7.2.64. | Comparing biomanufactured and conventional products (1) |
| 7.2.65. | Comparing biomanufactured and conventional products (2) |
| 7.2.66. | Comparing biomanufactured and conventional products (3) |
| 7.2.67. | Comparing biomanufactured and conventional products (4) |
| 7.2.68. | Biotech ingredients metrics comparison (1) |
| 7.2.69. | Biotech ingredients metrics comparison (2) |
| 7.2.70. | Biotech ingredient comparison metrics - IDTechEx framework (1) |
| 7.2.71. | Biotech ingredient comparison metrics - IDTechEx framework (2) |
| 7.2.72. | Outlook for biomanufactured beauty ingredients |
| 7.2.73. | General challenges for biomanufacturing in the beauty sector |
| 7.2.74. | Other emerging biomanufactured beauty products and status |
| 7.2.75. | Other emerging biomanufactured beauty products and status |
| 7.2.76. | Technology Readiness Level (TRL): Beauty products |
| 7.2.77. | Biomanufactured ingredients vs conventional alternatives |
| 7.2.78. | Biomanufactured ingredients vs conventional alternatives |
| 7.3. | Food additives |
| 7.3.1. | Vitamins |
| 7.3.2. | Vitamins produced using industrial biomanufacturing |
| 7.3.3. | Vitamin B2 (Riboflavin) |
| 7.3.4. | Vitamin B12 (Cobalamin) |
| 7.3.5. | Vitamin C (Ascorbic Acid) |
| 7.3.6. | Vitamin B7 (Biotin) |
| 7.3.7. | Vitamin B3 (Niacin / Nicotinic Acid) |
| 7.3.8. | Vitamin B9 (Folic Acid / Folate) |
| 7.3.9. | Amino Acids |
| 7.3.10. | Amino acids produced using industrial biomanufacturing |
| 7.3.11. | Lysine |
| 7.3.12. | Glutamate (Monosodium Glutamate, MSG) |
| 7.3.13. | Methionine |
| 7.3.14. | Technology Readiness Level (TRL): Food additives |
| 7.3.15. | Flavor Enhancers |
| 7.3.16. | Flavor enhancers |
| 7.3.17. | Disodium Inosinate (IMP) |
| 7.3.18. | Disodium Guanylate (GMP) |
| 7.3.19. | Sweeteners |
| 7.3.20. | Introduction to sweeteners |
| 7.3.21. | Sweeteners regional landscape |
| 7.3.22. | Biomanufacturing sweeteners: Overview |
| 7.3.23. | Rare sugars |
| 7.3.24. | Rare sugars: Commercial activity (1) |
| 7.3.25. | Rare sugars: Commercial activity (2) |
| 7.3.26. | Sugar alcohols (polyols) |
| 7.3.27. | Sugar alcohols: Commercial activity (1) |
| 7.3.28. | Sugar alcohols: Commercial activity (2) |
| 7.3.29. | High-potency sweeteners |
| 7.3.30. | High-potency sweeteners: Commercial activity (1) |
| 7.3.31. | High-potency sweeteners: Commercial activity (2) |
| 7.3.32. | Technology Readiness Level (TRL): Sweeteners |
| 7.4. | Enzymes |
| 7.4.1. | Overview |
| 7.4.2. | Overview: Industrial biomanufacturing for enzymes |
| 7.4.3. | Microbial platforms for industrial enzyme production (1) |
| 7.4.4. | Microbial platforms for industrial enzyme production (2) |
| 7.4.5. | Trends in enzyme production |
| 7.4.6. | Leading enzyme producers and technology providers |
| 7.4.7. | Enzymes for onward use: Novonesis |
| 7.4.8. | Competitive landscape of leading enzyme producers |
| 7.4.9. | Product strengths and weaknesses company comparison |
| 7.4.10. | Enzymes for Bioenergy Applications |
| 7.4.11. | Enzyme uses in biofuel production |
| 7.4.12. | Enzymes for bioenergy applications |
| 7.4.13. | Bioenergy value chain: Enzymes as enabling technologies |
| 7.4.14. | Technology Readiness Level (TRL): Enzymes for bioenergy applications |
| 7.4.15. | Technology Readiness Level (TRL): Enzymes for bioenergy applications |
| 7.4.16. | Cellulosic ethanol production overview |
| 7.4.17. | Cellulases for lignocellulosic bioethanol |
| 7.4.18. | Hemicellulases and synergistic enzyme cocktails |
| 7.4.19. | Xylanases and accessory enzymes in biomass hydrolysis |
| 7.4.20. | Amylases in first-generation bioethanol |
| 7.4.21. | Lipases for enzymatic biodiesel production |
| 7.4.22. | Oxidative enzymes (Laccases, Peroxidases) for biomass pretreatment |
| 7.4.23. | Thermostable and extremophilic enzymes for harsh processing conditions |
| 7.4.24. | Thermostable enzymes: Commercial examples and industrial applications |
| 7.4.25. | Cost-performance metrics for thermostable enzymes |
| 7.4.26. | Economic competitiveness of enzymatic bioenergy processing |
| 7.4.27. | Technology readiness levels of enzyme applications in bioenergy |
| 7.4.28. | Technology challenges and opportunities for bioenergy enzymes |
| 7.4.29. | Enzymes for Decarbonization and CO₂ Utilization |
| 7.4.30. | Enzymes as catalysts in low-carbon process development |
| 7.4.31. | Carbonic anhydrase in CO₂ capture technologies |
| 7.4.32. | Formate dehydrogenase and CO₂-to-chemicals pathways |
| 7.4.33. | Enzyme-coupled CO₂-to-Fuel or CO₂-to-chemical systems |
| 7.4.34. | Enzyme integration in CCUS |
| 7.4.35. | Barriers to commercial deployment of enzyme-based CO₂ systems |
| 7.4.36. | Selected enzymatic approaches to CO2 capture and conversion |
| 7.4.37. | Enzymes for Plastics Recycling |
| 7.4.38. | Enzymatic depolymerization overview |
| 7.4.39. | Enzymes used for plastics depolymerization (1) |
| 7.4.40. | Enzymes used for plastics depolymerization (2) |
| 7.4.41. | Enzymatic depolymerization of polyamides (nylon) |
| 7.4.42. | Challenges in enzymatic depolymerization |
| 7.4.43. | The challenges of mixed plastics for enzymatic depolymerization |
| 7.4.44. | The effect of contamination on enzyme activity |
| 7.4.45. | Companies pursuing enzyme recycling |
| 7.4.46. | SWOT analysis for enzyme recycling |
| 7.5. | Pigments and colorants |
| 7.5.1. | Introduction to pigments |
| 7.5.2. | Biomanufactured pigments: By color |
| 7.5.3. | Biomanufactured pigments: By color |
| 7.5.4. | Biomanufactured pigments: SWOT analysis |
| 7.5.5. | Carotenoids: Commercial activity |
| 7.5.6. | Blue and violet pigments: Overview |
| 7.5.7. | Blue and violet pigments: Commercial activity (1) |
| 7.5.8. | Blue and violet pigments: Commercial activity (2) |
| 7.5.9. | Red pigments: Overview |
| 7.5.10. | Red pigments: Commercial activity (1) |
| 7.5.11. | Red pigments: Commercial activity (2) |
| 7.5.12. | Melanin |
| 7.5.13. | Melanin: Commercial activity |
| 7.5.14. | Technology Readiness Level (TRL): Biomanufactured pigments |
| 8. | FORECASTS FOR BIOMANUFACTURING SPECIALTY CHEMICALS |
| 8.1. | IDTechEx Methodology |
| 8.2. | Methodology: Forecasting global capacity and market size (1) |
| 8.3. | Methodology: Forecasting global capacity and market size (2) |
| 8.4. | Biomanufactured specialty chemicals overall market 2027-2037 |
| 8.5. | Biomanufactured specialty chemicals overall market 2027-2037: Capacity |
| 8.6. | Biomanufactured specialty chemicals overall market 2027-2037: Market size |
| 8.7. | Biomanufactured specialty chemicals overall market 2027-2037: Market share |
| 8.8. | Biomanufactured food, beverage & nutrition chemicals 2027-2037 |
| 8.9. | Biomanufactured food, beverage & nutrition chemicals 2027-2037: Capacity |
| 8.10. | Biomanufactured food, beverage & nutrition chemicals 2027-2037: Market size |
| 8.11. | Biomanufactured cosmetics & personal care chemicals 2027-2037 |
| 8.12. | Biomanufactured cosmetics & personal care chemicals 2027-2037: Capacity |
| 8.13. | Biomanufactured cosmetics & personal care chemicals 2027-2037: Market size |
| 8.14. | Biomanufactured enzymes 2027-2037 |
| 8.15. | Biomanufactured enzymes 2027-2037: Capacity |
| 8.16. | Biomanufactured enzymes 2027-2037: Market size |
| 8.17. | Biomanufactured pigments and colorants 2027-2037 |
| 8.18. | Biomanufactured pigments and colorants 2027-2037: Capacity |
| 8.19. | Biomanufactured pigments and colorants 2027-2037: Market size |
| 9. | COMPANY PROFILES |
| 9.1. | 17Cicada |
| 9.2. | Afyren |
| 9.3. | Ambrosia Bio |
| 9.4. | Arzeda |
| 9.5. | Biomason |
| 9.6. | Biotic Circular Technologies |
| 9.7. | Bluepha |
| 9.8. | Bolt Threads |
| 9.9. | Braskem Bioplastics |
| 9.10. | CarbonBridge |
| 9.11. | Cathay Industrial Biotech |
| 9.12. | Celtic Renewables |
| 9.13. | Chaincraft |
| 9.14. | CJ Biomaterials |
| 9.15. | CyanoCapture |
| 9.16. | Danimer Scientific |
| 9.17. | Ecovative Forager |
| 9.18. | Enginzyme |
| 9.19. | Enzymaster |
| 9.20. | Fortum: INGA Plastic |
| 9.21. | Geno: 1,4-Butanediol |
| 9.22. | Geno: C6 Nylon Precursors |
| 9.23. | Henan Techuang Biotechnology |
| 9.24. | Holiferm |
| 9.25. | Huitong Biomaterials |
| 9.26. | Industrial Microbes |
| 9.27. | Kaneka: PHAs |
| 9.28. | Kraig Biocraft Laboratories |
| 9.29. | LanzaTech |
| 9.30. | Mango Materials |
| 9.31. | NatureWorks |
| 9.32. | New Energy Blue |
| 9.33. | Novozymes (now Novonesis) |
| 9.34. | Ourobio |
| 9.35. | Paques Biomaterials |
| 9.36. | Q Power |
| 9.37. | Shellworks |
| 9.38. | Solugen |
| 9.39. | Spiber |
| 9.40. | Teijin Frontier: PLA |
| 9.41. | TotalEnergies Corbion |